Faron Says Traumakine Trial Did Not Produce Expected Results
LONDON (Alliance News) - Faron Pharmaceuticals Ltd said Friday that initial review of the Phase III trial for Traumakine drug used for the treatment of lung inflammation did not produce the seen a Read More